You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Primary Sjögren's syndrome

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary Sjogren's Syndrome Trial (LY3361237)

Not yet recruiting
  • Primary Sjogren's Syndrome
  • (no location specified)
Mar 20, 2023

Primary Sjögren's Syndrome Trial (Efgartigimod, Placebo)

Not yet recruiting
  • Primary Sjögren's Syndrome
  • Efgartigimod
  • Placebo
  • (no location specified)
Apr 5, 2023

Sjogren's Syndrome Trial (Anifrolumab)

Recruiting
  • Sjogren's Syndrome
  • Groningen, Netherlands
    University Medical Centre Groningen
Dec 16, 2022

Primary Sjögren Syndrome Trial in Rochester (Ustekinumab)

Completed
  • Primary Sjögren Syndrome
  • Rochester, New York
    University of Rochester
Jul 6, 2022

Different Subtypes of Primary Sjogren Syndrome Related Dry Eye

Recruiting
  • Dry Eye
  • Cyclosporine
  • Beijing, China
    Peking University Third Hospital
Oct 30, 2022

Sjögren and Gynecologic Considerations

Completed
  • Primary Sjögren Syndrome
  • +3 more
  • Visual analogue scale (VAS) for dyspareunia
  • +3 more
  • Ankara, Turkey
    Ankara City Hospital
Jan 3, 2023

Primary Sjögren Syndrome Trial (68Ga-P16-093)

Not yet recruiting
  • Primary Sjögren Syndrome
  • (no location specified)
Sep 19, 2023

Healthy Participants, Primary Sjögren's Syndrome Trial in Berlin (BMS-986325, Placebo for BMS-986325)

Recruiting
  • Healthy Participants
  • Primary Sjögren's Syndrome
  • BMS-986325
  • Placebo for BMS-986325
  • Berlin, Germany
    Local Institution - 0001
Jul 11, 2022

Primary Sjögren Syndrome Patients

Active, not recruiting
  • Sjogren's Syndrome
  • Parallel Assignment
  • São Paulo, Sao Paulo, Brazil
  • +1 more
Nov 7, 2022

Primary Sjögren's Syndrome Painful Sensory Neuropathies Trial in Strasbourg (Privigen® 100mg/ml at the dose of 2g/kg of body

Recruiting
  • Primary Sjögren's Syndrome Painful Sensory Neuropathies
  • Privigen® 100mg/ml at the dose of 2g/kg of body weight
  • NaCl 0,9%
  • Strasbourg, France
    University Hospital, Strasbourg, france
Jul 7, 2022

Cutaneous Silent Period Assessment in Primary Sjögren's Syndrome

Completed
  • Small Fiber Neuropathy
  • Primary Sjögren Syndrome
  • cutaneous silent period (CSP) measurement
  • Istanbul, Pendik, Turkey
    Marmara University Pendik Education and Research Hospital
May 16, 2022

Primary Sjögren's Syndrome Trial in Hangzhou (Iguratimod Tablets, Hydroxychloroquine Sulfate Tablets)

Recruiting
  • Primary Sjögren's Syndrome
  • Iguratimod Tablets
  • Hydroxychloroquine Sulfate Tablets
  • Hangzhou, Zhejiang, China
    Second affiliated hospital of zhejiang university，school of medi
Mar 23, 2022

Primary Sjögren's Syndrome Trial in Beijing (Tofacitinib)

Recruiting
  • Primary Sjögren's Syndrome
  • Beijing, Beijing, China
    Department of Rheumatology and Immunology, Peking University Peo
Feb 28, 2022

Primary Sjögren's Syndrome (pSS) Trial in Le Kremlin-Bicêtre (Hydroxychloroquine 400mg/d, Leflunomide 20mg/d, Mycophenolate

Recruiting
  • Primary Sjögren's Syndrome (pSS)
  • Hydroxychloroquine 400mg/d
  • +5 more
  • Le Kremlin-Bicêtre, France
    Raphaele Seror
May 2, 2022

Sjogren's Syndrome Trial run by the National Institute of Dental and Craniofacial Research (NIDCR) (tofacitinib, Placebo)

Recruiting
  • Sjogren's Syndrome
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Nov 24, 2022

Sjögren Syndrome, Sicca Syndrome Trial in São Paulo (N-acetylcysteine syrup, Placebo syrup)

Active, not recruiting
  • Sjögren Syndrome
  • Sicca Syndrome
  • N-acetylcysteine syrup
  • Placebo syrup
  • São Paulo, Sao Paulo, Brazil
  • +1 more
Jun 13, 2022

Polymyalgia Rheumatica Associated to Primary Sjogren Syndrome

Recruiting
  • Polymyalgia Rheumatica
  • Sjogren's Syndrome
    • Brest, France
      CHRU Brest
    Mar 28, 2022

    Primary Sjögren's Syndrome (pSS) Trial in Seoul (SA001 Low dose, SA001 Mid dose, SA001 High dose)

    Completed
    • Primary Sjögren's Syndrome (pSS)
    • SA001 Low dose
    • +3 more
    • Seoul, Korea, Republic of
      Yonsei University Health System, Severance Hospital
    Mar 30, 2022

    Primary Sjögren's Syndrome Trial in Yantai (Placebo, RC18 240 mg, RC18 160 mg)

    Completed
    • Primary Sjögren's Syndrome
    • Placebo
    • +2 more
    • Yantai, Shandong, China
      Remegen,Ltd.
    Jan 7, 2022

    Primary Sjogren's Syndrome Trial in Palo Alto (tibulizumab (LY3090106))

    Withdrawn
    • Primary Sjogren's Syndrome
    • tibulizumab (LY3090106)
    • Palo Alto, California
      Stanford University
    Jan 12, 2022

    Sjogren's Syndrome Trial in Beijing (Baricitinib, Hydroxychloroquine)

    Recruiting
    • Sjogren's Syndrome
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Jul 17, 2022

    Sjogren's Syndrome, Fatigue, Pain Syndrome Trial in Yildirim (FACT-F questionnaire, Beck Depression Inventory, Beck Anxiety

    Completed
    • Sjogren's Syndrome
    • +5 more
    • FACT-F questionnaire
    • +6 more
    • Yıldırım, Bursa, Turkey
      Koray Ayar
    Nov 29, 2021

    Hand Functions in Newly Diagnosed Primary Sjögren's Syndrome

    Recruiting
    • Sjogren's Syndrome
    • digital dynamometer
    • Konya, Turkey
      Selcuk University
    Nov 4, 2021

    Primary Sjögren's Syndrome Trial in Berlin (VAY736, Placebo)

    Completed
    Has Results
    • Primary Sjögren's Syndrome
    • Berlin, Germany
      Novartis Investigative Site
    Sep 30, 2021

    Sjogren's Syndrome (SS) Trial in Utrecht (Ravaglimab, Ravagalimab, Placebo)

    Withdrawn
    • Sjogren's Syndrome (SS)
    • Utrecht, Netherlands
      Universitair Medisch Centrum Utrecht /ID# 214029
    Jan 20, 2022